A structured daily protocol helps maintain steady support for tissue repair and inflammation control throughout the healing process
S-adenosylmethionine (SAMe) as treatment for depression: a systematic review
A broader mechanistic review by Seiwerth and colleagues in Current Pharmaceutical Design laid out how BPC-157 seems to borrow the same angiogenic and growth-factor pathways the body uses to heal the gut, and apply them to tendon, ligament, muscle, and bone (Seiwerth et al., 2018)
The oversight is rigorous and appropriate for a pharmacy making one drug for one patient under a doctors prescription, Brunner told NPR
Potential Applications (Research Only) In controlled laboratory environments, BPC-157 is studied for: Examined for involvement in angiogenesis and vascular function in experimental systems
It is not a DEA-controlled substance as of 2025